CASE STUDY

Case Study

Case Study

Priority setting

Referring to the case of Mr. Levin and the supervision involved in this his treatment Alternatively, continuous administration of selective inhibitors with acceptable toxicity may permit targeting proteolytic activity throughout the span of the disease. Second, determination of the protease profile for each cancer type will help to target specific proteases on an individual basis with specific inhibitors, avoiding unwanted side effects. (Bennett 2008; Pp. 67-68)

Third, development of sensitive assays such as imaging to monitor inhibitor targeting and efficacy in tissues will help to validate drug effectiveness. Metastasis remains a bottleneck in effective intervention ...